Wen-Lin Luo

Title: The Innovations of Wen-Lin Luo in Parkinson's Disease Treatment

Introduction

Wen-Lin Luo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. His innovative approach to drug delivery systems has the potential to improve the quality of life for patients suffering from this debilitating condition.

Latest Patents

Wen-Lin Luo holds 1 patent for his work on di- and tri-peptide mimetic compounds aimed at treating Parkinson's disease. His patent describes a series of synthesized dopamine prodrugs that utilize D-phenylglycine or D-p-hydroxyphenylglycine. These compounds are designed to facilitate the delivery of L-dopa through the intestine via the intestinal dipeptide-mediated carrier transport system. This innovative method shows promise as an active ingredient for the treatment of Parkinson's disease.

Career Highlights

Wen-Lin Luo is affiliated with the Department of Health, the Executive Yuan, Republic of China. His work in this esteemed institution has allowed him to focus on research that bridges the gap between innovative drug development and practical medical applications. His dedication to improving patient outcomes is evident in his research and patent contributions.

Collaborations

Wen-Lin Luo has collaborated with several talented individuals in his field, including Jia-Shuai Lee and Hui-po Wang. These collaborations have fostered an environment of innovation and creativity, leading to advancements in the treatment of neurological disorders.

Conclusion

Wen-Lin Luo's contributions to the field of medicine, particularly in the treatment of Parkinson's disease, highlight the importance of innovation in healthcare. His patented work on peptide mimetic compounds represents a significant step forward in drug delivery systems. The potential impact of his research on patient care is profound and underscores the value of continued innovation in medical science.